Sitero Acquires studyOS to Build the Industry’s First AI-Driven CRO
In a move that could redefine how clinical trials are managed, Sitero has acquired the AI assets and business of studyOS, the startup behind Ash, the industry’s first AI clinical trial agent. The deal signals a major shift in how technology-enabled Clinical Research Organizations (CROs) are evolving—less as data managers, more as intelligent, automation-driven partners in accelerating drug development.
